Scott R. Ward, Director at InspireMD, Inc. (NSPR), bought 89,250 shares at $1.15 ($103K) on 2026-05-06, disclosed to the SEC on 2026-05-08.
Director Scott R. Ward purchased $18,394.25 worth of shares at $1.15, marking the largest purchase of his career and a reversal of his prior selling pattern. This significant insider accumulation comes as the stock trades near a 52-week low, potentially signaling confidence in the company's recent clinical data and FDA approval prospects.
The stock is down 34.77% over the last 90 days and is currently 61.29% below its 52-week high of $2.93, trading at $1.135. This decline places the current price just 7.08% above the 52-week low of $1.06.
The stock is down 56.35% over the last year, indicating significant investor skepticism regarding the company's long-term growth trajectory.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.15 | 15,995 | $18K | 17.9% |
| 2 | $1.15 | 73,255 | $84K | 82.1% |
| Total | $1.15 avg | 89,250 | $103K | 100% |
| Filing → |
| CSII | BUY | 2021-05-11 | $34K | — | Filing → |
| CSII | BUY | 2020-08-17 | $32K | — | Filing → |
| CSII | BUY | 2018-08-29 | $96K | — | Filing → |